Minimizing Carboplatin Hypersensitivity Reactions: A Role for Prescreening Intradermal Testing?

J Allergy Clin Immunol Pract. 2024 Apr;12(4):1006-1007. doi: 10.1016/j.jaip.2024.01.014.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Carboplatin / adverse effects
  • Drug Hypersensitivity* / diagnosis
  • Female
  • Humans
  • Intradermal Tests
  • Ovarian Neoplasms* / drug therapy

Substances

  • Carboplatin
  • Antineoplastic Agents